Bsh distributions in the canine head and a human patient using11b mri
- 1 July 1995
- journal article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 34 (1) , 48-56
- https://doi.org/10.1002/mrm.1910340109
Abstract
A 3D projection reconstruction (3DPR) method was used to obtain in vivo 11B images in a large canine brain tumor model and in a human infused with borocaptate sodium (BSH). Studies were performed in dogs with and without gliosarcomas implanted and grown to a size of 2-3 cm. The 3DPR method demonstrates a signal-to-noise ratio (SNR) that allows qualitative kinetic studies of the boron compound in normal and tumor tissue of the head. The measurements indicate initial uptake of the BSH compound in tumor to be less than that in muscle with no uptake in normal brain tissue. Moreover, uptake of BSH in tissue was found to lag the boron concentration in blood with delays that depend on tissue type. In addition, the first human boron images were obtained on a patient who underwent surgical resection and volumetric debulking of a large (7 cm) glioblastoma multiforme. BSH was readily taken up in residual tumor tissue, while diffusion into the resection volume was slower.Keywords
This publication has 6 references indexed in Scilit:
- Barriers to Drug Delivery in Solid TumorsScientific American, 1994
- Quantitative proton spectroscopy and histology of a canine brain tumor modelMagnetic Resonance in Medicine, 1993
- Boron‐11 imaging with a three‐dimensional reconstruction methodJournal of Magnetic Resonance Imaging, 1992
- Boron‐11 MRI and MRS of intact animals infused with a boron neutron capture agentMagnetic Resonance in Medicine, 1988
- Transplantable Canine Glioma Model for Use in Experimental Neuro-oncologyNeurosurgery, 1982
- The Uses of Nuclear Disintegration in the Diagnosis and Treatment of Brain TumorNew England Journal of Medicine, 1951